JY
SOPH icon

Jeff Yass’s SOPHiA GENETICS SOPH Stock Holding History

Jeff Yass’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,156
Closed -$66.8K – 14450
2026
Q1 		$65.1K Sell
13,156
-17,355
-57% -$84.4K ﹤0.01% 12545
2025
Q4 		$142K Buy
30,511
+12,032
+65% +$54.5K ﹤0.01% 11213
2025
Q3 		$88K Buy
+18,479
New +$63.5K ﹤0.01% 11644
2025
Q1 		– Sell
-14,835
Closed -$46.3K – 13392
2024
Q4 		$46.3K Buy
+14,835
New +$50.5K ﹤0.01% 11709

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Jeff Yass's SOPH Position: Q2 2026 in Review

Jeff Yass sold out of SOPHiA GENETICS (SOPH) in Q2 2026, closing a stake of 13,156 shares — an estimated $66.8K sold.

Jeff Yass first reported a position in SOPH in Q4 2024 and held it in 4 quarters. The position peaked at $142K in Q4 2025. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Jeff Yass reported no remaining SOPHiA GENETICS position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 13,156 SOPHiA GENETICS shares in Q2 2026, an estimated $66.8K.
  • Jeff Yass first reported a position in SOPHiA GENETICS in Q4 2024 and held it in 4 quarters.
  • Jeff Yass's SOPHiA GENETICS position peaked at $142K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.